Difference between revisions of "Pharma: UK libel law"
| Line 1: | Line 1: | ||
{{Template:Pharma_Portal_badge}} | {{Template:Pharma_Portal_badge}} | ||
| − | In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' <ref> Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.</ref> [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). <ref>Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.</ref> Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.<ref>Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist' Accessed 18 February 2010.</ref> Thomson released a statement claiming: | + | In February 2010, '''The Guardian''' reported that a Danish radiologist being sued for libel by [[GE Healthcare]], a subsidiary [[General Electric]], was launching a 'counterclaim for libel.' <ref> Leigh, D. ''The Guardian.'' 16 February 2010.[http://www.guardian.co.uk/science/2010/feb/16/scientist-libel-law-henrik-thomsen Danish scientist sued by drug firm under British libel laws to counterclaim] Accessed 18 February 2010.</ref> [[Henrik Thomsen]] previously claimed the company's contrast agent [[Omniscan]] which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). <ref>Booth, R. ''The Guardian.'' 20 December 2009. [http://www.guardian.co.uk/science/2009/dec/20/scientist-libel-law-henrik-thomsen UK libel law has gagged me, says leading Danish radiologist] Accessed 18 February 2010.</ref> Thomsen counter-sued the company for defamation after it called him a liar in a press release. '''GE Healthcare''' subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.<ref>Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.</ref> Thomson released a statement claiming: |
| − | :"I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF."<ref>Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist' Accessed 18 February 2010.</ref> | + | :"I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF."<ref>Leigh, D. 18 February 2010. ''The Guardian'' [http://www.guardian.co.uk/science/2010/feb/18/ge-healthcare-henrik-thomsen-libel US drug firm drops libel action against scientist'] Accessed 18 February 2010.</ref> |
==Notes== | ==Notes== | ||
Revision as of 18:39, 18 February 2010
|
This article is part of the Pharma_Portal project of Spinwatch. |
In February 2010, The Guardian reported that a Danish radiologist being sued for libel by GE Healthcare, a subsidiary General Electric, was launching a 'counterclaim for libel.' [1] Henrik Thomsen previously claimed the company's contrast agent Omniscan which is used in MRI scans caused a 'potentially fatal condition in some patients with kidney problems'. According to Thomsen, 30 patients at Copehnhagen University Hospital have developed nephrogenic systemic fibrosis (NSF). [2] Thomsen counter-sued the company for defamation after it called him a liar in a press release. GE Healthcare subsequently dropped the libel action claiming it 'did not mean to stifle academic debate'.[3] Thomson released a statement claiming:
- "I stand by my publicly expressed opinion, based on my experience and research on published papers, that there is an association between the chemical formulation of gadolinium-based contrast agents and NSF."[4]
Notes
- ↑ Leigh, D. The Guardian. 16 February 2010.Danish scientist sued by drug firm under British libel laws to counterclaim Accessed 18 February 2010.
- ↑ Booth, R. The Guardian. 20 December 2009. UK libel law has gagged me, says leading Danish radiologist Accessed 18 February 2010.
- ↑ Leigh, D. 18 February 2010. The Guardian US drug firm drops libel action against scientist' Accessed 18 February 2010.
- ↑ Leigh, D. 18 February 2010. The Guardian US drug firm drops libel action against scientist' Accessed 18 February 2010.
